Catalyst Wire Dossier Catalyst Wire Dossier

Dendritic cell vaccine loaded with autologous tumor homogenate

dendritic cell vaccine loaded with autologous tumor homogenate · Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Dendritic cell vaccine loaded with autologous tumor homogenate, covering 2024-09-19 to 2024-09-19. Get the full timeline:

Most recent: Clinical Trial Update: A Phase II Study on Adjuvant Vaccination with Dendritic Cells Loaded with Autologous Tumor Homogenate in Resected Stage IV Rare Cancers. [Phase 2]

See pricing